Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Selma Blair discussed her heartbreaking MS relapse during a candid chat on Tuesday's Drew Barrymore Show. The actress, 52, who was diagnosed with multiple sclerosis in 2018, said during a past relapse ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

After a multiple sclerosis diagnosis, travel became nearly impossible for Selma Blair. At California’s iconic — and accessible — Rosewood Miramar Beach, the actor shares her advice on getting back out ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...